A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/00 (2006.01) A61K 9/06 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/70 (2006.01) A61K 38/00 (2006.01) A61K 38/22 (2006.01) A61K 38/25 (2006.01) A61K 38/28 (2006.01) A61K 38/29 (2006.01) A61K 38/31 (2006.01) A61M 5/142 (2006.01) A61J 1/00 (2006.01) A61K 47/26 (2006.01) A61M 5/315 (2006.01)
Patent
CA 2198917
The invention features a solid, non-particulate, sustained-release pharmaceutical composition for parenteral administration to a patient. The composition consists essentially of: (1) a soluble, gelable peptide salt, and (2) up to 30 percent by weight of a pharmaceutically acceptable, monomeric, soluble carrier, compounded into a solid cylindrical form, wherein the solid composition automatically forms a gel after interaction with the patient's bodily fluids, the gel releasing the peptide continuously within the patient over an extended period of at least three days.
L'invention concerne une composition pharmaceutique solide, non particulaire et à libération prolongée destinée à être administrée par voie parentérale à un patient. La composition comprend essentiellement: (1) un sel peptidique gélifiable soluble; et (2) jusqu'à 30 % en poids d'un véhicule monomère soluble et pharmaceutiquement acceptable, se présentant une forme galénique solide cylindrique, la composition solide formant automatiquement un gel après l'interaction avec les liquides biologiques du patient, le gel libérant le peptide en continu dans le corps du patient sur une période prolongée d'au moins trois jours.
Ipsen Pharma S.a.s
Smart & Biggar
Societe de Conseils de Recherches Et D'applications Scientifique
LandOfFree
Sustained release of peptides from pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release of peptides from pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release of peptides from pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1728766